Indian HealthTech startup CURAPOD has raised ₹20 crore in fresh funding to scale up the manufacturing of its pain management device, marking a significant milestone in its journey to make non-invasive pain relief more accessible across the country. The funding round comes at a time when India’s medical devices ecosystem is witnessing increased investor interest, driven by rising healthcare demand, domestic manufacturing push, and growing awareness around chronic pain management.
According to the company, the newly raised capital will be primarily used to expand manufacturing capacity, invest in advanced tooling and automation, and strengthen quality control processes. CURAPOD also plans to
...
